RADNOR, Pa. and DUBLIN, Nov. 6, 2019 /PRNewswire/ — Avantor, Inc. (NYSE: AVTR) and the National Institute of Bioprocessing Research and Training (NIBRT) today announced they are teaming up to address downstream bottlenecks in buffer preparation when producing monoclonal antibodies (mAbs). As part of the joint effort, Avantor® is providing in-line dilution systems for hands-on experience at NIBRT’s prestigious training and research facility dedicated to supporting the global bioprocessing industry. Avantor’s technology adds to NIBRT’s full complement of bioprocessing capabilities.
{iframe}https://www.biospace.com/article/releases/avantor-and-nibrt-collaborate-to-advance-bioprocessing-by-addressing-downstream-bottlenecks-in-monoclonal-antibodies-mabs-production/{/iframe}